Location: Home
  • search
  • go
  • Relate News
  • 10/10/2024QuantumPharma's Subsidiary Ailux Biologics Partners with Janssen Biote...
  • 10/10/2024Nona Biosciences Enters Strategic Collaboration with OverT Bio to Adva...
  • 10/10/2024InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...
  • 10/10/2024Eli Lilly Submits Chinese NDA for Its Anti-IL23 Antibody Mirikizumab
  • 10/10/2024CDE Solicits Comments on the Proposed Announcement on Rewarding Intern...
  • 10/10/2024CDE Issues the Technical Guidelines for the Analysis and Handling of S...
  • 10/10/2024Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...
  • 10/10/2024Mainland China's Pharmaceutical Sales to Reach $345B by 2033: BMI/Fitc...
  • 10/10/2024Leads Biolabs Receives Breakthrough Therapy Designation in China for E...
  • 10/10/2024Bio-Thera Secures $110M Drug Licensing Deal with Hungary's Gedeon Rich...
  • 10/9/2024NMPA Announces Package Insert Revision of Mezlocillin Sodium Containin...
  • 10/9/2024Bayer Launches Life Sciences Incubator in Shanghai
  • 10/9/2024US Venture Capital Opens Funding Opportunities for China Biotech Firms
  • 10/9/2024SMEI: Chinese Terminal Drug Market Grew 5.2% in 2023
  • 10/9/2024IQVIA Releases the 2024 White Paper on Development Trends in China's O...
  • 10/8/2024MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...
  • 10/8/2024AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal wort...
  • 10/8/2024Innovent and Ask Pharm Enter Strategic Deal for Limertinib 
  • 10/8/2024Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...
  • 10/8/2024Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor
  • 10/8/2024BeiGene Initiates Phase I Trial for FGFR2b ADC BG-C137 in Advanced Sol...
  • 10/8/2024China to Establish a Unified Mapping Database for Traceability Codes, ...
  • 10/8/2024Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
  • 10/8/2024Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
  • 10/8/2024BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...
  • 10/8/2024CDE Issues the List of Reference Formulations for GQCE Studies (83rd B...
  • 10/8/2024CSPC Announces Regulatory Milestones in China and the U.S.
  • 10/8/2024AstraZeneca Expanding R&D pipeline in China
  • 10/8/2024Aadi Bio Wins Arbitration, Rejecting Multimillion-Dollar Claim from Ch...
  • 10/8/2024CStone to Report Positive Preclinical Data of Anticancer Candidate CS2...
  • Page:62/790 Total number of articles:23683: [First][<<] [60] [61] [62] [63] [64] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group